Search

Search Constraints

You searched for: Author/Creator Tokunaga, E.

Search Results

3. P018 TROPION-Breast03: Datopotamab deruxtecan (Dato-DXd) ± durvalumab vs investigator's choice of therapy (ICT) for triple-negative breast cancer (TNBC) with residual disease following neoadjuvant therapy. (April 2023)